Literature DB >> 3353626

Assessing and modeling heterosexual spread of the human immunodeficiency virus in the United States.

V De Gruttola1, K H Mayer.   

Abstract

Epidemiologic investigation of the AIDS epidemic among heterosexuals has consisted chiefly of studies of partners of individuals infected with the human immunodeficiency virus (HIV) and population surveillance. Heterosexual partners of infected individuals appear to be at high risk of infection, but only a small proportion of cases of AIDS have been attributed to heterosexual contact in the United States and Europe. An epidemic model for heterosexual spread of HIV infection is developed and fit to surveillance data. Fitted values are restricted to a range consistent with findings from partner studies. Because, at present, most HIV-infected heterosexuals and bisexuals have been infected through other means (intravenous drug use or homosexual contact), the model considers two interacting populations: a small population of individuals rapidly infected by high-risk activity and a large population of individuals at risk only from heterosexual contact. No precise predictions concerning the AIDS epidemic among heterosexuals are possible now, but current epidemiologic findings neither predict nor preclude a major heterosexual epidemic. Projections depend strongly on the delay between infection and infectivity. The model can also be used to demonstrate how interpretation of results of case-control studies of HIV infection depends on underlying assumptions about the dynamics of the epidemic.

Entities:  

Mesh:

Year:  1988        PMID: 3353626     DOI: 10.1093/clinids/10.1.138

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  Milk and yoghurt do not impair the absorption of ofloxacin.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

2.  Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence.

Authors:  J E Siegel; M C Weinstein; H V Fineberg
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

3.  Risk behavior-based model of the cubic growth of acquired immunodeficiency syndrome in the United States.

Authors:  S A Colgate; E A Stanley; J M Hyman; S P Layne; C Qualls
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal.

Authors:  C Donnelly; W Leisenring; P Kanki; T Awerbuch; S Sandberg
Journal:  Bull Math Biol       Date:  1993       Impact factor: 1.758

5.  Pilot study of AIDS risk in the general population.

Authors:  R W Jeffery; G L Burke; T L Schmid; J Ma
Journal:  Public Health Rep       Date:  1992 Jan-Feb       Impact factor: 2.792

6.  A new approach to estimating AIDS incubation times: results in homosexual infected men.

Authors:  S Chevret; D Costagliola; J J Lefrere; A J Valleron
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

Review 7.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

8.  Avoiding risky sex partners: perception of partners' risks v partners' self reported risks.

Authors:  B P Stoner; W L H Whittington; S O Aral; J P Hughes; H H Handsfield; K K Holmes
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

9.  HIV-1 seroconversion and risk behaviors among young men in the US army. The Seroconversion Risk Factor Study Group.

Authors:  L I Levin; T A Peterman; P O Renzullo; V Lasley-Bibbs; X O Shu; J F Brundage; J G McNeil
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

10.  AIDS and COVID: A tale of two pandemics and the role of statisticians.

Authors:  Susan S Ellenberg; Jeffrey S Morris
Journal:  Stat Med       Date:  2021-05-20       Impact factor: 2.373

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.